Risks for preeclampsia and small for gestational age: Predictive values of placental growth factor, soluble fms-like tyrosine kinase-1, and inhibin a in singleton and multiple-gestation pregnancies

American Journal of Perinatology

Volumn 30, Issue 7, 2013, Pages 607-612

  Boucoiran, Isabelle ^a   Thissier Levy, Sarah ^a   Wu, Yuquan ^a   Wei, Shu Qin ^a   Luo, Zhong Cheng ^a   Delvin, Edgard ^a   Fraser, Williamd ^a   Audibert, Francois ^a  

^a UNIVERSITY OF MONTREAL   (Canada)

Author keywords

multiple gestation; PlGF; preeclampsia; sFlt 1; small for gestational age

Indexed keywords

ANTIOXIDANT; CD135 ANTIGEN; INHIBIN A; PLACENTAL GROWTH FACTOR;

ACCURACY; ADULT; ARTICLE; COHORT ANALYSIS; FALSE POSITIVE RESULT; FEMALE; GESTATIONAL AGE; HUMAN; MAJOR CLINICAL STUDY; MULTIPLE PREGNANCY; PREDICTIVE VALUE; PREECLAMPSIA; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROTEIN BLOOD LEVEL; RISK ASSESSMENT; SENSITIVITY ANALYSIS; SMALL FOR DATE INFANT; SUPPLEMENTATION;

ADULT; AREA UNDER CURVE; BIOLOGICAL MARKERS; FALSE POSITIVE REACTIONS; FEMALE; HUMANS; INFANT, NEWBORN; INFANT, SMALL FOR GESTATIONAL AGE; INHIBINS; PRE-ECLAMPSIA; PREDICTIVE VALUE OF TESTS; PREGNANCY; PREGNANCY PROTEINS; PREGNANCY, TRIPLET; PREGNANCY, TWIN; ROC CURVE; VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR-1;

EID: 84880332197     PISSN: 07351631     EISSN: 10988785     Source Type: Journal    
DOI: 10.1055/s-0032-1329691     Document Type: Article

References (27)

1. Steegers E. A., von Dadelszen P., Duvekot J. J., Pijnenborg R. Pre-eclampsia. Lancet: 2010; 376 631 644
2. Duckitt K., Harrington D. Risk factors for pre-eclampsia at antenatal booking: systematic review of controlled studies. BMJ: 2005; 330 565
3. Sibai B. M., Hauth J., Caritis S., et al. National Institute of Child Health and Human Development Network of Maternal-Fetal Medicine Units Hypertensive disorders in twin versus singleton gestations. Am J Obstet Gynecol: 2000; 182 938 942 (Pubitemid 30228471)
4. Sherer D. M. Adverse perinatal outcome of twin pregnancies according to chorionicity: review of the literature. Am J Perinatol: 2001; 18 23 37 (Pubitemid 32245012)
5. Powe C. E., Levine R. J., Karumanchi S. A. Preeclampsia, a disease of the maternal endothelium: the role of antiangiogenic factors and implications for later cardiovascular disease. Circulation: 2011; 123 2856 2869
6. Romero R., Nien J. K., Espinoza J., et al. A longitudinal study of angiogenic (placental growth factor) and anti-angiogenic (soluble endoglin and soluble vascular endothelial growth factor receptor-1) factors in normal pregnancy and patients destined to develop preeclampsia and deliver a small for gestational age neonate. J Matern Fetal Neonatal Med: 2008; 21 9 23
7. Shibata E., Rajakumar A., Powers R. W., et al. Soluble fms-like tyrosine kinase 1 is increased in preeclampsia but not in normotensive pregnancies with small-for-gestational-age neonates: relationship to circulating placental growth factor. J Clin Endocrinol Metab: 2005; 90 4895 4903 (Pubitemid 41159388)
8. Lambert-Messerlian G. M., Palomaki G. E., Neveux L. M., et al. Early onset preeclampsia and second trimester serum markers. Prenat Diagn: 2009; 29 1109 1117
9. Audibert F., Boucoiran I., An N., et al. Screening for preeclampsia using first-trimester serum markers and uterine artery Doppler in nulliparous women. Am J Obstet Gynecol: 2010; 203 383, e1-e8
10. Poon L. C., Kametas N. A., Maiz N., Akolekar R., Nicolaides K. H. First-trimester prediction of hypertensive disorders in pregnancy. Hypertension: 2009; 53 812 818
11. Sibai B. M., Koch M. A., Freire S., et al. Serum inhibin A and angiogenic factor levels in pregnancies with previous preeclampsia and/or chronic hypertension: are they useful markers for prediction of subsequent preeclampsia? Am J Obstet Gynecol: 2008; 199 268, e1-e9
12. Verlohren S., Galindo A., Schlembach D., et al. An automated method for the determination of the sFlt-1/PIGF ratio in the assessment of preeclampsia. Am J Obstet Gynecol: 2010; 202 161, e1-e161, e11
13. Levine R. J., Maynard S. E., Qian C., et al. Circulating angiogenic factors and the risk of preeclampsia. N Engl J Med: 2004; 350 672 683 (Pubitemid 38364626)
14. Morris R. K., Cnossen J. S., Langejans M., et al. Serum screening with Down's syndrome markers to predict pre-eclampsia and small for gestational age: systematic review and meta-analysis. BMC Pregnancy Childbirth: 2008; 8 33
15. Akolekar R., Minekawa R., Veduta A., Romero X. C., Nicolaides K. H. Maternal plasma inhibin A at 11-13 weeks of gestation in hypertensive disorders of pregnancy. Prenat Diagn: 2009; 29 753 760
16. Maymon R., Cuckle H., Herman A. Maternal serum inhibin levels in twin and singleton pregnancies conceived by assisted reproduction. Hum Reprod: 2006; 21 1305 1308
17. Maynard S. E., Moore Simas T. A., Solitro M. J., et al. Circulating angiogenic factors in singleton vs multiple-gestation pregnancies. Am J Obstet Gynecol: 2008; 198 200, e1-e7
18. Sánchez O., Llurba E., Marsal G., et al. First trimester serum angiogenic/anti-angiogenic status in twin pregnancies: relationship with assisted reproduction technology. Hum Reprod: 2012; 27 358 365
19. Bdolah Y., Lam C., Rajakumar A., et al. Twin pregnancy and the risk of preeclampsia: bigger placenta or relative ischemia? Am J Obstet Gynecol: 2008; 198 428, e1-e6
20. Xu H., Perez-Cuevas R., Xiong X., et al. INTAPP study group An international trial of antioxidants in the prevention of preeclampsia (INTAPP). Am J Obstet Gynecol: 2010; 202 239, e1-e239, e10
21. Brown M. A., Lindheimer M. D., de Swiet M., Van Assche A., Moutquin J. M. The classification and diagnosis of the hypertensive disorders of pregnancy: statement from the International Society for the Study of Hypertension in Pregnancy (ISSHP). Hypertens Pregnancy: 2001; 20 IX XIV (Pubitemid 32672922)
22. Kramer M. S., Platt R. W., Wen S. W., et al. Fetal/Infant Health Study Group of the Canadian Perinatal Surveillance System A new and improved population-based Canadian reference for birth weight for gestational age. Pediatrics: 2001; 108 E35
23. Akolekar R., Zaragoza E., Poon L. C., Pepes S., Nicolaides K. H. Maternal serum placental growth factor at 11 + 0 to 13 + 6 weeks of gestation in the prediction of pre-eclampsia. Ultrasound Obstet Gynecol: 2008; 32 732 739
24. Cowans N. J., Alfthan H., Stenman U. H., Spencer K. Stability of first trimester placental growth factor in serum and whole blood. Prenat Diagn: 2011; 31 1193 1197
25. Tsatsaris V., Goffin F., Munaut C., et al. Overexpression of the soluble vascular endothelial growth factor receptor in preeclamptic patients: pathophysiological consequences. J Clin Endocrinol Metab: 2003; 88 5555 5563 (Pubitemid 37452769)
26. Benton S. J., Hu Y., Xie F., et al. Can placental growth factor in maternal circulation identify fetuses with placental intrauterine growth restriction? Am J Obstet Gynecol: 2012; 206 163, e1-e7
27. Blickstein I. Normal and abnormal growth of multiples. Semin Neonatol: 2002; 7 177 185